Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?.

Epilepsy research and treatment

Mansouri A, Aldakkan A, Kosicka MJ, Tarride JE, Valiante TA.
PMID: 26770822
Epilepsy Res Treat. 2015;2015:675071. doi: 10.1155/2015/675071. Epub 2015 Dec 07.

Objective. Surgery for medically refractory epilepsy (MRE) in adults has been shown to be effective but underutilized. Comprehensive health economic evaluations of surgery compared with continued medical management are limited. Policy changes may be necessary to influence practice shift....

Cite
Mansouri A, Aldakkan A, Kosicka MJ, et al. Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?. Epilepsy Res Treat. 2015;2015:675071doi: 10.1155/2015/675071.
Mansouri, A., Aldakkan, A., Kosicka, M. J., Tarride, J. E., & Valiante, T. A. (2015). Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?. Epilepsy research and treatment, 2015675071. https://doi.org/10.1155/2015/675071
Mansouri, Alireza, et al. "Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?." Epilepsy research and treatment vol. 2015 (2015): 675071. doi: https://doi.org/10.1155/2015/675071
Mansouri A, Aldakkan A, Kosicka MJ, Tarride JE, Valiante TA. Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?. Epilepsy Res Treat. 2015;2015:675071. doi: 10.1155/2015/675071. Epub 2015 Dec 07. PMID: 26770822; PMCID: PMC4685103.
Copy Download .nbib Format: NLM
Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Dziarmaga A, Reidel K, White R, Tarride JE, Corner N.
PMID: 27200896
Value Health. 2014 Nov;17(7):A390. doi: 10.1016/j.jval.2014.08.2666. Epub 2014 Oct 26.

No abstract available.

Cite
Dziarmaga A, Reidel K, White R, et al. Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As). Value Health. 2014;17(7):A390doi: 10.1016/j.jval.2014.08.2666.
Dziarmaga, A., Reidel, K., White, R., Tarride, J. E., & Corner, N. (2014). Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A390. https://doi.org/10.1016/j.jval.2014.08.2666
Dziarmaga, A, et al. "Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A390. doi: https://doi.org/10.1016/j.jval.2014.08.2666
Dziarmaga A, Reidel K, White R, Tarride JE, Corner N. Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As). Value Health. 2014 Nov;17(7):A390. doi: 10.1016/j.jval.2014.08.2666. Epub 2014 Oct 26. PMID: 27200896.
Copy Download .nbib Format: NLM
How does the canadian general public rate moderate Alzheimer's disease?.

Journal of aging research

Tarride JE, Oremus M, Pullenayegum E, Clayton N, Raina P.
PMID: 22229093
J Aging Res. 2011;2011:682470. doi: 10.4061/2011/682470. Epub 2011 Dec 20.

Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered...

Cite
Tarride JE, Oremus M, Pullenayegum E, et al. How does the canadian general public rate moderate Alzheimer's disease?. J Aging Res. 2011;2011:682470doi: 10.4061/2011/682470.
Tarride, J. E., Oremus, M., Pullenayegum, E., Clayton, N., & Raina, P. (2011). How does the canadian general public rate moderate Alzheimer's disease?. Journal of aging research, 2011682470. https://doi.org/10.4061/2011/682470
Tarride, Jean-Eric, et al. "How does the canadian general public rate moderate Alzheimer's disease?." Journal of aging research vol. 2011 (2011): 682470. doi: https://doi.org/10.4061/2011/682470
Tarride JE, Oremus M, Pullenayegum E, Clayton N, Raina P. How does the canadian general public rate moderate Alzheimer's disease?. J Aging Res. 2011;2011:682470. doi: 10.4061/2011/682470. Epub 2011 Dec 20. PMID: 22229093; PMCID: PMC3250621.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents.

ClinicoEconomics and outcomes research : CEOR

Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R.
PMID: 23055756
Clinicoecon Outcomes Res. 2012;4:287-98. doi: 10.2147/CEOR.S33444. Epub 2012 Oct 04.

BACKGROUND: Influenza affects all age groups and is common in children. Between 15% and 42% of preschool- and school-aged children experience influenza each season. Recently, intranasal live attenuated influenza vaccine, trivalent (LAIV) has been approved in Canada.OBJECTIVE: The objective...

Cite
Tarride JE, Burke N, Von Keyserlingk C, et al. Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res. 2012;4:287-98doi: 10.2147/CEOR.S33444.
Tarride, J. E., Burke, N., Von Keyserlingk, C., O'Reilly, D., Xie, F., & Goeree, R. (2012). Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. ClinicoEconomics and outcomes research : CEOR, 4287-98. https://doi.org/10.2147/CEOR.S33444
Tarride, Jean-Eric, et al. "Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents." ClinicoEconomics and outcomes research : CEOR vol. 4 (2012): 287-98. doi: https://doi.org/10.2147/CEOR.S33444
Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R. Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res. 2012;4:287-98. doi: 10.2147/CEOR.S33444. Epub 2012 Oct 04. PMID: 23055756; PMCID: PMC3468276.
Copy Download .nbib Format: NLM
Superoleophobic Meshes with Relatively Low Hysteresis and Sliding Angles by Electropolymerization: Importance of Polymer-Growth Control.

ChemPlusChem

Darmanin T, Tarrade J, Celia E, Bellanger H, Guittard F.
PMID: 31986613
Chempluschem. 2014 Mar;79(3):334. doi: 10.1002/cplu.201300392. Epub 2013 Dec 17.

Invited for this month's cover is the group of Prof. Frederic Guittard from Université Nice Sophia-Antipolis. The cover picture shows a superoleophobic stainless-steel mesh obtained by electrodeposition of fluorinated conducting polymers. Read the full text of the article at...

Cite
Darmanin T, Tarrade J, Celia E, et al. Superoleophobic Meshes with Relatively Low Hysteresis and Sliding Angles by Electropolymerization: Importance of Polymer-Growth Control. Chempluschem. 2013;79(3):334doi: 10.1002/cplu.201300392.
Darmanin, T., Tarrade, J., Celia, E., Bellanger, H., & Guittard, F. (2014). Superoleophobic Meshes with Relatively Low Hysteresis and Sliding Angles by Electropolymerization: Importance of Polymer-Growth Control. ChemPlusChem, 79(3), 334. https://doi.org/10.1002/cplu.201300392
Darmanin, Thierry, et al. "Superoleophobic Meshes with Relatively Low Hysteresis and Sliding Angles by Electropolymerization: Importance of Polymer-Growth Control." ChemPlusChem vol. 79,3 (2014): 334. doi: https://doi.org/10.1002/cplu.201300392
Darmanin T, Tarrade J, Celia E, Bellanger H, Guittard F. Superoleophobic Meshes with Relatively Low Hysteresis and Sliding Angles by Electropolymerization: Importance of Polymer-Growth Control. Chempluschem. 2014 Mar;79(3):334. doi: 10.1002/cplu.201300392. Epub 2013 Dec 17. PMID: 31986613.
Copy Download .nbib Format: NLM
Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study.

JMIR mHealth and uHealth

McGillion M, Dvirnik N, Yang S, Belley-Côté E, Lamy A, Whitlock R, Marcucci M, Borges F, Duceppe E, Ouellette C, Bird M, Carroll SL, Conen D, Tarride JE, Harsha P, Scott T, Good A, Gregus K, Sanchez K, Benoit P, Owen J, Harvey V, Peter E, Petch J, Vincent J, Graham M, Devereaux PJ.
PMID: 34876396
JMIR Mhealth Uhealth. 2021 Nov 12; doi: 10.2196/24916. Epub 2021 Nov 12.

BACKGROUND: Continuous hemodynamic monitoring is the standard of care for patients intraoperatively, but vital signs monitoring is performed only periodically on post-surgical wards, and patients are routinely discharged home with no surveillance. Wearable continuous monitoring biosensor technologies have the...

Cite
McGillion M, Dvirnik N, Yang S, et al. Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study. JMIR Mhealth Uhealth. 2021;doi: 10.2196/24916.
McGillion, M., Dvirnik, N., Yang, S., Belley-Côté, E., Lamy, A., Whitlock, R., Marcucci, M., Borges, F., Duceppe, E., Ouellette, C., Bird, M., Carroll, S. L., Conen, D., Tarride, J. E., Harsha, P., Scott, T., Good, A., Gregus, K., Sanchez, K., Benoit, P., Owen, J., Harvey, V., Peter, E., Petch, J., Vincent, J., Graham, M., & Devereaux, P. J. (2021). Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study. JMIR mHealth and uHealth, . https://doi.org/10.2196/24916
McGillion, Michael, et al. "Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study." JMIR mHealth and uHealth vol. (2021). doi: https://doi.org/10.2196/24916
McGillion M, Dvirnik N, Yang S, Belley-Côté E, Lamy A, Whitlock R, Marcucci M, Borges F, Duceppe E, Ouellette C, Bird M, Carroll SL, Conen D, Tarride JE, Harsha P, Scott T, Good A, Gregus K, Sanchez K, Benoit P, Owen J, Harvey V, Peter E, Petch J, Vincent J, Graham M, Devereaux PJ. Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study. JMIR Mhealth Uhealth. 2021 Nov 12; doi: 10.2196/24916. Epub 2021 Nov 12. PMID: 34876396.
Copy Download .nbib Format: NLM
Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity.

JAMA network open

Doumouras AG, Lee Y, Paterson JM, Gerstein HC, Shah BR, Sivapathasundaram B, Tarride JE, Anvari M, Hong D.
PMID: 33900401
JAMA Netw Open. 2021 Apr 01;4(4):e216820. doi: 10.1001/jamanetworkopen.2021.6820.

IMPORTANCE: There are high-quality randomized clinical trial data demonstrating the effect of bariatric surgery on type 2 diabetes remission, but these studies are not powered to study mortality in this patient group. Large observational studies are warranted to study...

Cite
Doumouras AG, Lee Y, Paterson JM, et al. Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity. JAMA Netw Open. 2021;4(4):e216820doi: 10.1001/jamanetworkopen.2021.6820.
Doumouras, A. G., Lee, Y., Paterson, J. M., Gerstein, H. C., Shah, B. R., Sivapathasundaram, B., Tarride, J. E., Anvari, M., & Hong, D. (2021). Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity. JAMA network open, 4(4), e216820. https://doi.org/10.1001/jamanetworkopen.2021.6820
Doumouras, Aristithes G, et al. "Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity." JAMA network open vol. 4,4 (2021): e216820. doi: https://doi.org/10.1001/jamanetworkopen.2021.6820
Doumouras AG, Lee Y, Paterson JM, Gerstein HC, Shah BR, Sivapathasundaram B, Tarride JE, Anvari M, Hong D. Association Between Bariatric Surgery and Major Adverse Diabetes Outcomes in Patients With Diabetes and Obesity. JAMA Netw Open. 2021 Apr 01;4(4):e216820. doi: 10.1001/jamanetworkopen.2021.6820. PMID: 33900401; PMCID: PMC8076963.
Copy Download .nbib Format: NLM
Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study.

JMIR mHealth and uHealth

McGillion M, Dvirnik N, Yang S, Belley-Côté E, Lamy A, Whitlock R, Marcucci M, Borges F, Duceppe E, Ouellette C, Bird M, Carroll SL, Conen D, Tarride JE, Harsha P, Scott T, Good A, Gregus K, Sanchez K, Benoit P, Owen J, Harvey V, Peter E, Petch J, Vincent J, Graham M, Devereaux PJ.
PMID: 34876396
JMIR Mhealth Uhealth. 2021 Nov 12; doi: 10.2196/24916. Epub 2021 Nov 12.

BACKGROUND: Continuous hemodynamic monitoring is the standard of care for patients intraoperatively, but vital signs monitoring is performed only periodically on post-surgical wards, and patients are routinely discharged home with no surveillance. Wearable continuous monitoring biosensor technologies have the...

Cite
McGillion M, Dvirnik N, Yang S, et al. Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study. JMIR Mhealth Uhealth. 2021;doi: 10.2196/24916.
McGillion, M., Dvirnik, N., Yang, S., Belley-Côté, E., Lamy, A., Whitlock, R., Marcucci, M., Borges, F., Duceppe, E., Ouellette, C., Bird, M., Carroll, S. L., Conen, D., Tarride, J. E., Harsha, P., Scott, T., Good, A., Gregus, K., Sanchez, K., Benoit, P., Owen, J., Harvey, V., Peter, E., Petch, J., Vincent, J., Graham, M., & Devereaux, P. J. (2021). Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study. JMIR mHealth and uHealth, . https://doi.org/10.2196/24916
McGillion, Michael, et al. "Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study." JMIR mHealth and uHealth vol. (2021). doi: https://doi.org/10.2196/24916
McGillion M, Dvirnik N, Yang S, Belley-Côté E, Lamy A, Whitlock R, Marcucci M, Borges F, Duceppe E, Ouellette C, Bird M, Carroll SL, Conen D, Tarride JE, Harsha P, Scott T, Good A, Gregus K, Sanchez K, Benoit P, Owen J, Harvey V, Peter E, Petch J, Vincent J, Graham M, Devereaux PJ. Continuous non-invasive remote automated blood pressure monitoring with novel wearable technology: A Validation Study. JMIR Mhealth Uhealth. 2021 Nov 12; doi: 10.2196/24916. Epub 2021 Nov 12. PMID: 34876396.
Copy Download .nbib Format: NLM
Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology.

PharmacoEconomics - open

Ball G, Levine M, Thabane L, Tarride JE.
PMID: 33893974
Pharmacoecon Open. 2021 Sep;5(3):397-410. doi: 10.1007/s41669-021-00263-w. Epub 2021 Apr 24.

INTRODUCTION: The type of methods used in economic evaluations of health technology can lead to results that may influence decisions. Despite the potential impact on decision making, there is very little documentation of methods used in economic evaluation in...

Cite
Ball G, Levine M, Thabane L, et al. Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology. Pharmacoecon Open. 2021;5(3):397-410doi: 10.1007/s41669-021-00263-w.
Ball, G., Levine, M., Thabane, L., & Tarride, J. E. (2021). Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology. PharmacoEconomics - open, 5(3), 397-410. https://doi.org/10.1007/s41669-021-00263-w
Ball, Graeme, et al. "Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology." PharmacoEconomics - open vol. 5,3 (2021): 397-410. doi: https://doi.org/10.1007/s41669-021-00263-w
Ball G, Levine M, Thabane L, Tarride JE. Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology. Pharmacoecon Open. 2021 Sep;5(3):397-410. doi: 10.1007/s41669-021-00263-w. Epub 2021 Apr 24. PMID: 33893974; PMCID: PMC8333159.
Copy Download .nbib Format: NLM
A Comparison of Confounder Selection and Adjustment Methods for Estimating Causal Effects Using Large Healthcare Databases.

Pharmacoepidemiology and drug safety

Benasseur I, Talbot D, Durand M, Holbrook A, Matteau A, Potter BJ, Renoux C, Schnitzer ME, Tarride JÉ, Guertin JR.
PMID: 34953160
Pharmacoepidemiol Drug Saf. 2021 Dec 25; doi: 10.1002/pds.5403. Epub 2021 Dec 25.

PURPOSE: Confounding adjustment is required to estimate the effect of an exposure on an outcome in observational studies. However, variable selection and unmeasured confounding are particularly challenging when analyzing large healthcare data. Machine learning methods may help address these...

Cite
Benasseur I, Talbot D, Durand M, et al. A Comparison of Confounder Selection and Adjustment Methods for Estimating Causal Effects Using Large Healthcare Databases. Pharmacoepidemiol Drug Saf. 2021;doi: 10.1002/pds.5403.
Benasseur, I., Talbot, D., Durand, M., Holbrook, A., Matteau, A., Potter, B. J., Renoux, C., Schnitzer, M. E., Tarride, J. �. �., & Guertin, J. R. (2021). A Comparison of Confounder Selection and Adjustment Methods for Estimating Causal Effects Using Large Healthcare Databases. Pharmacoepidemiology and drug safety, . https://doi.org/10.1002/pds.5403
Benasseur, Imane, et al. "A Comparison of Confounder Selection and Adjustment Methods for Estimating Causal Effects Using Large Healthcare Databases." Pharmacoepidemiology and drug safety vol. (2021). doi: https://doi.org/10.1002/pds.5403
Benasseur I, Talbot D, Durand M, Holbrook A, Matteau A, Potter BJ, Renoux C, Schnitzer ME, Tarride JÉ, Guertin JR. A Comparison of Confounder Selection and Adjustment Methods for Estimating Causal Effects Using Large Healthcare Databases. Pharmacoepidemiol Drug Saf. 2021 Dec 25; doi: 10.1002/pds.5403. Epub 2021 Dec 25. PMID: 34953160.
Copy Download .nbib Format: NLM
Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Schemitsch E, Adachi JD, Brown JP, Tarride JE, Burke N, Oliveira T, Slatkovska L.
PMID: 34379148
Osteoporos Int. 2021 Aug 11; doi: 10.1007/s00198-021-06080-5. Epub 2021 Aug 11.

In this real-world retrospective cohort, subsequent hip fracture occurred in one in four patients with any initial fracture, most often after hip fracture, on average within 1.5 years. These data support the need for early post-fracture interventions to help...

Cite
Schemitsch E, Adachi JD, Brown JP, et al. Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporos Int. 2021;doi: 10.1007/s00198-021-06080-5.
Schemitsch, E., Adachi, J. D., Brown, J. P., Tarride, J. E., Burke, N., Oliveira, T., & Slatkovska, L. (2021). Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, . https://doi.org/10.1007/s00198-021-06080-5
Schemitsch, Emil, et al. "Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. (2021). doi: https://doi.org/10.1007/s00198-021-06080-5
Schemitsch E, Adachi JD, Brown JP, Tarride JE, Burke N, Oliveira T, Slatkovska L. Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporos Int. 2021 Aug 11; doi: 10.1007/s00198-021-06080-5. Epub 2021 Aug 11. PMID: 34379148; PMCID: PMC8354846.
Copy Download .nbib Format: NLM
A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions.

ClinicoEconomics and outcomes research : CEOR

Foroutan N, Tarride JE, Xie F, Levine M.
PMID: 30538513
Clinicoecon Outcomes Res. 2018 Nov 26;10:821-854. doi: 10.2147/CEOR.S178825. eCollection 2018.

INTRODUCTION: Budget impact analysis (BIA) in health care, sometimes referred to as resource impact, is the financial change in the use of health resources associated with adding a new drug to a formulary or the adoption of a new...

Cite
Foroutan N, Tarride JE, Xie F, et al. A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions. Clinicoecon Outcomes Res. 2018;10:821-854doi: 10.2147/CEOR.S178825.
Foroutan, N., Tarride, J. E., Xie, F., & Levine, M. (2018). A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions. ClinicoEconomics and outcomes research : CEOR, 10821-854. https://doi.org/10.2147/CEOR.S178825
Foroutan, Naghmeh, et al. "A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions." ClinicoEconomics and outcomes research : CEOR vol. 10 (2018): 821-854. doi: https://doi.org/10.2147/CEOR.S178825
Foroutan N, Tarride JE, Xie F, Levine M. A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions. Clinicoecon Outcomes Res. 2018 Nov 26;10:821-854. doi: 10.2147/CEOR.S178825. eCollection 2018. PMID: 30538513; PMCID: PMC6263295.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries